Tuesday, November 18, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

R1 RCM Stock Surges Following Lucrative Acquisition Offer

Elaine Mendonca by Elaine Mendonca
February 26, 2024
in Breaking News
0
Healthcare cloud based
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

On February 26, 2024, R1 RCM is seeing a surge in its stock price following a lucrative acquisition offer of $13.75 per share. The company, known for its expertise in revenue cycle management, has garnered a “Moderate Buy” rating from analysts, who have set an average target price of $18.00.

In a recent strategic move, R1 RCM acquired Acclara for a hefty sum of $675 million in cash, along with a warrant allowing the purchase of up to 12.2 million shares of R1 stock at a strike price of $10.52. This acquisition further solidifies R1’s position in the competitive revenue cycle management industry, showcasing the company’s commitment to growth and expansion.

R1 RCM Inc. (RCM) Stock Surges 27.21% on February 26, 2024: Market Analysis

On February 26, 2024, R1 RCM Inc. (RCM) saw a significant increase in its stock performance. According to data from CNN Money, RCM is currently trading in the middle of its 52-week range and above its 200-day simple moving average, indicating a stable position in the market.

The price of RCM shares experienced a notable increase on this particular day, rising by $3.02 since the previous market close. This represents a substantial 27.21% increase in value, signaling positive momentum for the stock.

RCM opened at $14.05 on February 26th, which was $2.96 higher than its previous closing price. This strong opening suggests that investors were optimistic about the company’s prospects and were willing to pay a premium for RCM shares.

RCM Technologies, Inc. Reports Mixed Financial Results on February 26, 2024: Revenue Up, Net Income Down

On February 26, 2024, RCM Technologies, Inc. (RCM) reported its stock performances based on the financial data provided by CNN Money. The company’s total revenue for the past year was $1.81 billion, showing an increase of 22.5% compared to the previous year. However, the total revenue remained flat at $572.80 million for the third quarter.

In terms of net income, RCM reported a net loss of $63.30 million for the past year, which represents a significant decrease of 165.12% compared to the previous year. On the other hand, the net income for the third quarter was $1.30 million, showing an increase of 230.0% since the previous quarter.

Earnings per share (EPS) for RCM were reported at -$0.18 for the past year and $0.00 for the third quarter. This represents an increase of 90.34% in EPS since the previous year and a significant increase of 216.67% since the previous quarter.

Overall, the financial performance of RCM on February 26, 2024, showed mixed results. While the total revenue saw a significant increase compared to the previous year, the net income showed a significant decrease. However, the EPS for the company showed positive growth both year-over-year and quarter-over-quarter.

Investors and analysts will continue to monitor RCM’s financial performance in the coming quarters.

Tags: RCM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Cleanest energy and ev

The Potential of Renewable Energy Integration: Harnessing Electric Vehicles as Grid Assets

Finance_ Charts for stock trading

Truist Securities Analyst Maintains Hold Rating on Main Street Capital with Increased Price Target

Biopharmaceutical Markets and money (1)

FDA Approval of Tevas SIMLANDI A GameChanger in Arthritis Treatment

Recommended

Papa John's Stock

Papa John’s Stock Gains Momentum from Expansion and Strong Earnings

3 months ago
SolarEdge Stock

SolarEdge Shares Surge on Strong Quarterly Performance

3 months ago
Aqua Metals Stock

Aqua Metals Stock: Deep-Sea Venture and Earnings Report Set Stage for Volatility

1 week ago
Industrial Metals and Mining Stock Exchange

Prominent Industrial REITs for Income in 2024

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Is the Fidelity High Dividend ETF Headed for a Downturn?

Bioatla Shares Surge on Strong Clinical and Financial Results

MediaAlpha Insiders Exit Positions Amid Strong Quarterly Results

Travelzoo’s Persistent Decline: A Deep Dive into the Challenges

Aclaris Therapeutics Stock: Poised for a Breakout Year?

Ionis Shares Surge on Strong Financials and Clinical Breakthroughs

Trending

Skye Bioscience Stock
Analysis

Skye Bioscience Shares Plunge as Investor Lawsuit Filed

by Dieter Jaworski
November 18, 2025
0

Skye Bioscience's stock is experiencing another significant downturn this week as the biotechnology firm faces a new...

Ishares Msci Acwi ETF Stock

Is the iShares MSCI ACWI ETF’s Record Run Nearing Its End?

November 18, 2025
PennantPark Floating Rate Capital Stock

Understanding PennantPark’s Dividend Day Price Adjustment

November 18, 2025
Fidelity® High Dividend ETF Stock

Is the Fidelity High Dividend ETF Headed for a Downturn?

November 18, 2025
Bioatla Inc Stock

Bioatla Shares Surge on Strong Clinical and Financial Results

November 18, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Skye Bioscience Shares Plunge as Investor Lawsuit Filed
  • Is the iShares MSCI ACWI ETF’s Record Run Nearing Its End?
  • Understanding PennantPark’s Dividend Day Price Adjustment

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com